Stay updated on Granix Disruption in Myeloma Transplant Clinical Trial

Sign up to get notified when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Granix Disruption in Myeloma Transplant Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T23:02:02.000Z thumbnail image
  6. Check
    12 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in a randomized phase II trial comparing the effectiveness of adding XMO2 Filgrastim (Granix) to melphalan before a stem cell transplant in treating patients with multiple myeloma.
    Difference
    0.1%
    Check dated 2024-06-06T14:49:11.000Z thumbnail image
  7. Check
    27 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns medical and healthcare-related publications and documentation, specifically regarding the eligibility criteria for researchers looking for participants in clinical research studies.
    Difference
    26%
    Check dated 2024-05-21T19:01:32.000Z thumbnail image
  8. Check
    48 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:53:30.000Z thumbnail image

Stay in the know with updates to Granix Disruption in Myeloma Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.